Article Text

Download PDFPDF
Association between polymorphisms in microRNA seed region and warfarin stable dose
  1. Maryam Hosseindokht1,
  2. Hamed Zare2,
  3. Rasoul Salehi1,
  4. Leyla Pourgholi3,
  5. Shayan Ziaee3,
  6. Mohammadali Boroumand3,
  7. Mohammadreza Sharifi1
  1. 1Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Islamic Republic of Iran
  2. 2Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Islamic Republic of Iran
  3. 3Department of Pathology and Laboratory Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
  1. Correspondence to Dr Mohammadreza Sharifi, Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan 81744-176, Islamic Republic of Iran; mo_sharifi{at}med.mui.ac.ir; Dr Mohammadali Boroumand, Department of Pathology and Laboratory Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran; maboroumand{at}yahoo.com

Abstract

Background The optimal dose of anticoagulant warfarin varies among patients to achieve the target international normalised ratio. Although genetic variations related to warfarin pharmacokinetics and vitamin K cycle are important factors associated with warfarin dose requirements, these variations do not completely explain the large interindividual variability observed in the most populations, suggesting that additional factors may contribute to this variability. microRNAs have recently been introduced as regulators of drug function genes, and therefore, may be involved in drug responses. In this study, we aimed to evaluate the possible association between variants in the seed region of microRNAs, which target the genes involved in the action of warfarin and warfarin dose requirement.

Methods 526 samples were collected from Iranian patients. Four selected polymorphisms in the seed region of microRNAs (rs2910164, rs66683138, rs12416605 and rs35770269 in miR-146a, miR-3622a, miR-938 and miR-449c, respectively) were genotyped by PCR-restriction fragment length polymorphism method.

Results rs2910164 C/G in the seed region of miR-146a was associated with warfarin dose requirement (p<0.001); the patients with GG genotype had the higher mean dose of warfarin (40.6 mg/week, compared with 33.9 and 31.8 mg/week for GC and CC genotypes, respectively). The association of other polymorphisms with warfarin dose requirement was not statistically significant.

Conclusion rs2910164 C/G in the seed region of miR-146a is associated with warfarin maintenance dose, likely by disrupting interaction between miR-146a and ATP-binding cassette subfamily B member 1 gene, ABCB1. Therefore, this polymorphism may possibly be a potential factor for assessment of warfarin dose requirements.

  • clinical pharmacology
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors MH, MB and MS: designed and performed experiments, analysed data and cowrote the paper. LP, HZ and SZ: performed experiments. HZ: performed bioinformatic analyses. MS, MB and RS: supervised the research.

  • Funding This study was supported by Isfahan University of Medical Sciences (grant number: 396319).

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval This study was approved by the local ethics committee of Isfahan University of Medical Sciences, IRAN. The studies have been approved by the appropriate institutional and/or a national research ethics committee and have been performed, in accordance with the ethical standards, as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement Data are available on reasonable request.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.